World Health Organization is endorsing the usage of Paxlovid for mild and moderate COVID-19 patients at highest risk of hospital admission. The data shows that the risk of hospitalization is reduced by 85% following this treatment.
World Health Organization is endorsing the usage of Paxlovid for mild and moderate COVID-19 patients at highest risk of hospital admission. The data shows that the risk of hospitalization is reduced by 85% following this treatment.